ofatumumab - Arzerra; HuMax-CD20; CD20 monoclonal antibody, human, recombinant -- Product Record

CD20 Mab, human, rDNA

    Nomenclature:
      CD20 Mab, human, rDNA [BIO]
      Arzerra [TR]
      ofatumumab [FDA]
      ofatumumab [INN]
      immunoglobulin G1, anti-(human CD20 (antigen))(human monoclonal HuMax-CD20 heavy chain), disulfide with human monoclonal HuMax-CD20 kappa-chain, dimer [CAS]
      679818-59-8 [CAS RN]
      CD20 monoclonal antibody, human, recombinant [SY]
      NDC 0173-0808-02 and NDC 0173-0808-05 [NDC]

    molecular weight (kDa) = 149

    FDA Class:  Biologic BLA

    Year of approval (FDA) = 2009